FIELD: medicine.
SUBSTANCE: group of inventions concerns orthopedy and traumatology and can be applicable for treatment and assistance to cartilage and-or bone formation. CXCL6 is administered to the patient requiring it, thus the specified CXCL6 represents wild type CXCL6 or its modified version keeping chemotactic activity concerning chondrocytes and chondrocytes precursor cells. The group of inventions provides complete elimination of a defect by a hyaline cartilage of normal structure.
EFFECT: complete elimination of a defect by a hyaline cartilage of normal structure.
22 cl, 3 ex, 2 tbl, 3 dwg
